Brown and beige adipose tissue regulate systemic metabolism through a metabolite interorgan signaling axis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 03 2021
Historique:
received: 26 06 2020
accepted: 05 03 2021
entrez: 27 3 2021
pubmed: 28 3 2021
medline: 13 4 2021
Statut: epublish

Résumé

Brown and beige adipose tissue are emerging as distinct endocrine organs. These tissues are functionally associated with skeletal muscle, adipose tissue metabolism and systemic energy expenditure, suggesting an interorgan signaling network. Using metabolomics, we identify 3-methyl-2-oxovaleric acid, 5-oxoproline, and β-hydroxyisobutyric acid as small molecule metabokines synthesized in browning adipocytes and secreted via monocarboxylate transporters. 3-methyl-2-oxovaleric acid, 5-oxoproline and β-hydroxyisobutyric acid induce a brown adipocyte-specific phenotype in white adipocytes and mitochondrial oxidative energy metabolism in skeletal myocytes both in vitro and in vivo. 3-methyl-2-oxovaleric acid and 5-oxoproline signal through cAMP-PKA-p38 MAPK and β-hydroxyisobutyric acid via mTOR. In humans, plasma and adipose tissue 3-methyl-2-oxovaleric acid, 5-oxoproline and β-hydroxyisobutyric acid concentrations correlate with markers of adipose browning and inversely associate with body mass index. These metabolites reduce adiposity, increase energy expenditure and improve glucose and insulin homeostasis in mouse models of obesity and diabetes. Our findings identify beige adipose-brown adipose-muscle physiological metabokine crosstalk.

Identifiants

pubmed: 33772024
doi: 10.1038/s41467-021-22272-3
pii: 10.1038/s41467-021-22272-3
pmc: PMC7998027
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1905

Subventions

Organisme : Medical Research Council
ID : MC_UU_00014/2
Pays : United Kingdom
Organisme : Diabetes UK
ID : 16/0005382
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_13030
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R013500/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P011705/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/H013539/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802051
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R014086/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A090_1006
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400192
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/5
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/7/33636
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P01836X/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/12/13/29853
Pays : United Kingdom

Références

Endocrinology. 2011 Dec;152(12):4641-51
pubmed: 21990309
NMR Biomed. 2006 Apr;19(2):271-8
pubmed: 16541463
Cell Metab. 2009 Feb;9(2):203-9
pubmed: 19187776
J Clin Invest. 2013 Jan;123(1):215-23
pubmed: 23221344
Cell Metab. 2009 Apr;9(4):311-26
pubmed: 19356713
Cell Res. 2013 Jun;23(6):851-4
pubmed: 23649313
Nat Chem Biol. 2018 Nov;14(11):1021-1031
pubmed: 30327559
Diabetes. 2014 Oct;63(10):3253-65
pubmed: 24789919
Nat Rev Endocrinol. 2014 Dec;10(12):723-36
pubmed: 25287287
Cell Metab. 2012 May 2;15(5):606-14
pubmed: 22560213
Trends Endocrinol Metab. 2017 Dec;28(12):855-867
pubmed: 29113711
Endocrinology. 1996 Jan;137(1):21-9
pubmed: 8536614
Cell Metab. 2008 May;7(5):410-20
pubmed: 18460332
Genome Biol. 2011 Aug 11;12(8):R75
pubmed: 21843327
Nat Med. 2016 Apr;22(4):421-6
pubmed: 26950361
Hum Mol Genet. 2018 Oct 15;27(20):3641-3649
pubmed: 30124842
Nature. 1993 Dec 23-30;366(6457):740-2
pubmed: 8264795
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):529-541
pubmed: 28493406
Cell. 2012 Jul 20;150(2):366-76
pubmed: 22796012
Diabetes. 2015 Feb;64(2):471-484
pubmed: 25249574
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7849-54
pubmed: 24825887
J Inherit Metab Dis. 1993;16(4):648-69
pubmed: 8412012
Mol Metab. 2018 Mar;9:192-198
pubmed: 29396369
Mol Cell Biol. 2004 Apr;24(7):3057-67
pubmed: 15024092
Cell. 1999 Jul 9;98(1):115-24
pubmed: 10412986
PLoS Med. 2008 Mar 11;5(3):e51
pubmed: 18336063
J Vis Exp. 2012 Apr 04;(62):e3680
pubmed: 22508524
Cell Metab. 2018 Oct 2;28(4):656-666.e1
pubmed: 30017358
Cell Metab. 2007 Jul;6(1):38-54
pubmed: 17618855
Pharm Res. 2019 Apr 17;36(6):84
pubmed: 30997560
Nature. 2019 Aug;572(7771):614-619
pubmed: 31435015
Mol Aspects Med. 2013 Apr-Jun;34(2-3):337-49
pubmed: 23506875
Cell Metab. 2014 Jan 7;19(1):96-108
pubmed: 24411942
Cell Metab. 2019 Feb 5;29(2):417-429.e4
pubmed: 30449684
J Biol Chem. 2015 Jan 23;290(4):2303-11
pubmed: 25371203
Mol Cell Biol. 2001 Jan;21(1):319-29
pubmed: 11113206
Cell Metab. 2013 Jul 2;18(1):43-50
pubmed: 23770128
J Lipid Res. 1997 Oct;38(10):2125-33
pubmed: 9374134
EMBO Rep. 2017 Dec;18(12):2172-2185
pubmed: 29066459
Nature. 2000 Apr 6;404(6778):652-60
pubmed: 10766252
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
Nat Med. 2011 Apr;17(4):448-53
pubmed: 21423183
IUBMB Life. 2012 Jan;64(1):1-9
pubmed: 22131303
Proc Natl Acad Sci U S A. 1985 Jan;82(2):445-8
pubmed: 3855564
J Clin Invest. 2011 Jan;121(1):96-105
pubmed: 21123942
Diabetes. 2017 Mar;66(3):674-688
pubmed: 28028076
J Biol Chem. 2001 Jul 20;276(29):27077-82
pubmed: 11369767
Nat Commun. 2020 Jan 31;11(1):624
pubmed: 32005798
J Lipid Res. 1989 Nov;30(11):1811-7
pubmed: 2614280
Nature. 1997 May 1;387(6628):90-4
pubmed: 9139827
Biochem J. 1999 Oct 15;343 Pt 2:281-99
pubmed: 10510291
J Biol Chem. 2010 Apr 9;285(15):11348-56
pubmed: 20093359
Front Physiol. 2013 Jun 04;4:128
pubmed: 23760815
Genes Dev. 2013 Feb 1;27(3):234-50
pubmed: 23388824
Biochem Biophys Res Commun. 2010 Sep 24;400(3):318-22
pubmed: 20727852
Cell Metab. 2018 Oct 2;28(4):631-643.e3
pubmed: 30078553
J Clin Invest. 2003 Feb;111(3):399-407
pubmed: 12569166
Nat Med. 2015 Jul;21(7):760-8
pubmed: 26076036
Diabetes. 2010 Jul;59(7):1789-93
pubmed: 20357363
Lancet Diabetes Endocrinol. 2014 Jan;2(1):65-75
pubmed: 24622670
Biochem Med. 1975 Nov;14(3):339-45
pubmed: 1225334
Cell. 2003 Apr 18;113(2):159-70
pubmed: 12705865
J Clin Invest. 2016 May 2;126(5):1704-16
pubmed: 27018708
Cell. 2014 Jan 16;156(1-2):20-44
pubmed: 24439368
Sci Rep. 2015 Aug 11;5:13091
pubmed: 26260892

Auteurs

Anna Whitehead (A)

School of Medicine, University of Leeds, Leeds, UK.

Fynn N Krause (FN)

Department of Biochemistry, University of Cambridge, Cambridge, UK.

Amy Moran (A)

School of Medicine, University of Leeds, Leeds, UK.

Amanda D V MacCannell (ADV)

School of Medicine, University of Leeds, Leeds, UK.

Jason L Scragg (JL)

School of Medicine, University of Leeds, Leeds, UK.

Ben D McNally (BD)

Department of Biochemistry, University of Cambridge, Cambridge, UK.

Edward Boateng (E)

School of Medicine, University of Leeds, Leeds, UK.

Steven A Murfitt (SA)

Department of Biochemistry, University of Cambridge, Cambridge, UK.

Samuel Virtue (S)

Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

John Wright (J)

School of Medicine, University of Leeds, Leeds, UK.

Jack Garnham (J)

School of Medicine, University of Leeds, Leeds, UK.

Graeme R Davies (GR)

Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

James Dodgson (J)

Phenotypic Screening and High Content Imaging, Antibody Discovery & Protein Engineering, R&D, AstraZeneca, Cambridge, UK.

Jurgen E Schneider (JE)

School of Medicine, University of Leeds, Leeds, UK.

Andrew J Murray (AJ)

Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.

Christopher Church (C)

Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Antonio Vidal-Puig (A)

Institute of Metabolic Science, University of Cambridge, Cambridge, UK.

Klaus K Witte (KK)

School of Medicine, University of Leeds, Leeds, UK.

Julian L Griffin (JL)

Department of Biochemistry, University of Cambridge, Cambridge, UK.

Lee D Roberts (LD)

School of Medicine, University of Leeds, Leeds, UK. L.D.Roberts@leeds.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH